Home › Funds › Cormorant Asset Management, LP › BHVN
Cormorant Asset Management, LP position in BHVN
BIOHAVEN LTD · Health Care
Cormorant Asset Management, LP reported holding 2,610,000 shares of BHVN (BIOHAVEN LTD) in its Q2 2026 13F filing — a position valued at US$38.8M, representing 1.99% of its reported portfolio and ranking #18 among its reported holdings. Cormorant Asset Management, LP has disclosed BHVN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's BHVN position evolved
Cormorant Asset Management, LP first disclosed a stake in BHVN in Q3 2023 at 81,963 shares (US$2.1M). The position peaked in Q2 2026 at 2,610,000 shares, worth US$38.8M. Across 12 filings, Cormorant Asset Management, LP increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 2,610,000 shares valued at US$38.8M — an increase of 850,000 shares quarter over quarter.. Notable position changes include a 653% increase in Q1 2024 (shares fell 37% over the following quarter), a 86% trim in Q4 2024 (shares fell 36% over the following quarter), a 17500% increase in Q1 2026 (shares rose 76% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 81.96K | $2.13M | New |
| Q4 2023 | 81.96K | $3.51M | Hold |
| Q1 2024 | 616.96K | $33.74M | Add |
| Q2 2024 | 801.96K | $27.84M | Add |
| Q3 2024 | 401.96K | $20.09M | Reduce |
| Q4 2024 | 55.54K | $2.07M | Reduce |
| Q1 2025 | 10.00K | $240.40K | Reduce |
| Q2 2025 | 10.00K | $141.10K | Hold |
| Q3 2025 | 10.00K | $150.10K | Hold |
| Q4 2025 | 10.00K | $112.90K | Hold |
| Q1 2026 | 1.76M | $14.89M | Add |
| Q2 2026 | 2.61M | $38.84M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BHVN and 13F data
BHVN (BIOHAVEN LTD) is a Health Care company. 29 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BHVN
- MONTANOVA CAPITAL, LLC 10.29M sh · $153.07M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 6.25M sh · $93.00M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.94M sh · $43.70M · Q2 2026
- Knoll Capital Management, LLC 2.35M sh · $35.01M · Q2 2026
- TCG Crossover Management, LLC 1.78M sh · $26.49M · Q2 2026
- ARS Investment Partners, LLC 1.37M sh · $20.45M · Q2 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held BHVN?
Cormorant Asset Management, LP has disclosed BHVN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Cormorant Asset Management, LP's current position in BHVN?
As of Q2 2026, Cormorant Asset Management, LP holds 2.61M shares of BHVN (BIOHAVEN LTD), valued at $38.84M, representing 1.99% of its reported portfolio and ranking #18.
Has Cormorant Asset Management, LP been buying or selling BHVN?
In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP increased its position in BHVN. The position peaked in Q2 2026 at 2.61M shares.
Which other funds hold BHVN?
Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.